These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 3891675)

  • 1. The biochemistry of schizophrenia--a review.
    Shelley RK; Walsh N
    Ir Med J; 1985 May; 78(5):139-43. PubMed ID: 3891675
    [No Abstract]   [Full Text] [Related]  

  • 2. Neurotransmitters and CNS disease. Schizophrenia.
    Snyder SH
    Lancet; 1982 Oct; 2(8305):970-4. PubMed ID: 6127468
    [No Abstract]   [Full Text] [Related]  

  • 3. Changes in cerebral dopamine metabolism and receptors during one-year neuroleptic administration and subsequent withdrawal: relevance to brain biochemistry in schizophrenia.
    Clow A; Jenner P; Theodorou A; Marsden CD
    Adv Biochem Psychopharmacol; 1980; 24():53-5. PubMed ID: 6105799
    [No Abstract]   [Full Text] [Related]  

  • 4. The neuropathology of schizophrenia.
    Stevens JR
    Psychol Med; 1982 Nov; 12(4):695-700. PubMed ID: 7156246
    [No Abstract]   [Full Text] [Related]  

  • 5. Ligand selection for PET studies of D1 dopamine receptors. Relationship between distribution of binding sites and mRNA for DAARPP32 in the human brain.
    Sedvall CG; Farde L; Hall H; Halldin C; Karlsson P; Brene S; Lindefors N; Persson H; Chipkin RE; Ehrlich M
    Clin Neuropharmacol; 1992; 15 Suppl 1 Pt A():466A-467A. PubMed ID: 1386781
    [No Abstract]   [Full Text] [Related]  

  • 6. Elevated D2 in schizophrenia: role of endogenous dopamine and cerebellum. Commentary on "The current status of PET scanning with respect to schizophrenia".
    Seeman P
    Neuropsychopharmacology; 1992 Aug; 7(1):55-7; discussion 73-5. PubMed ID: 1388022
    [No Abstract]   [Full Text] [Related]  

  • 7. CT scans in schizophrenia.
    Reveley MA
    Br J Psychiatry; 1985 Apr; 146():367-71. PubMed ID: 3893596
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo imaging of baboon and human dopamine transporters by positron emission tomography using [11C]WIN 35,428.
    Wong DF; Yung B; Dannals RF; Shaya EK; Ravert HT; Chen CA; Chan B; Folio T; Scheffel U; Ricaurte GA
    Synapse; 1993 Oct; 15(2):130-42. PubMed ID: 8259524
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Brain imaging in schizophrenia -- especially by Computed Tomography].
    Szulc A
    Psychiatr Pol; 1994; 28(2):145-56. PubMed ID: 8208861
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Schizophrenia and cerebral atrophy.
    Weinberger DR; Wyatt RJ
    Lancet; 1980 May; 1(8178):1130. PubMed ID: 6103454
    [No Abstract]   [Full Text] [Related]  

  • 11. Implications of positron emission tomography research for the investigation of the actions of antipsychotic drugs.
    List SJ; Cleghorn JM
    Br J Psychiatry Suppl; 1993 Dec; (22):25-30. PubMed ID: 7906522
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How schizophrenia develops: new evidence and new ideas.
    Harv Ment Health Lett; 2001 Feb; 17(8):1-4. PubMed ID: 11175456
    [No Abstract]   [Full Text] [Related]  

  • 13. PET studies of neuroreceptors in schizophrenia. Commentary on "The current status of PET scanning with respect to schizophrenia".
    Wong DF
    Neuropsychopharmacology; 1992 Aug; 7(1):69-72; discussion 73-5. PubMed ID: 1388023
    [No Abstract]   [Full Text] [Related]  

  • 14. Positron emission tomography--examination of chemical transmission in the living human brain. Development of radioligands.
    Farde L; Hall H
    Arzneimittelforschung; 1992 Feb; 42(2A):260-4. PubMed ID: 1316756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Etiology and expression of schizophrenia: neurobiological and psychosocial factors.
    Mirsky AF; Duncan CC
    Annu Rev Psychol; 1986; 37():291-319. PubMed ID: 3485954
    [No Abstract]   [Full Text] [Related]  

  • 16. Neuroleptics, dopamine, and schizophrenia.
    Pickar D
    Psychiatr Clin North Am; 1986 Mar; 9(1):35-48. PubMed ID: 2870480
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Schizophrenia and dopamine (author's transl)].
    Toru M
    Tanpakushitsu Kakusan Koso; 1978; 23(4):303-16. PubMed ID: 26107
    [No Abstract]   [Full Text] [Related]  

  • 18. Commentary on "The current status of PET scanning with respect to schizophrenia".
    Buchsbaum MS
    Neuropsychopharmacology; 1992 Aug; 7(1):67-8; discussion 73-5. PubMed ID: 1355970
    [No Abstract]   [Full Text] [Related]  

  • 19. PET scanning in schizophrenia, a critical evaluation. Commentary on "The current status of PET scanning with respect to schizophrenia".
    Murphy D; Rapoport SI
    Neuropsychopharmacology; 1992 Aug; 7(1):59-61; discussion 73-5. PubMed ID: 1524656
    [No Abstract]   [Full Text] [Related]  

  • 20. Chemical brain anatomy in schizophrenia.
    Sedvall G; Farde L
    Lancet; 1995 Sep; 346(8977):743-9. PubMed ID: 7658878
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.